Kula Investments’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,019
Closed -$469K 745
2022
Q4
$469K Buy
+7,019
New +$469K 0.14% 233